Wenfeng Zeng

4PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Transport properties and non-equilibrium processesMolecular targetsInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 23, 2026
Multivalent Peptide-Guided EZH2 Degradation Sensitizes Immune Checkpoint Therapy in TNBC.

Minxian Li, Haipeng Zhao, Lilusi Ma

|Jun 24, 2024
PKM2, the "K+ sink" in the tumor interstitial fluid.

Wenjing Na, Wenfeng Zeng, Kai Song

|Oct 01, 2021
Downregulating testosterone levels enhance immunotherapy efficiency.

Luoyang Wang, Guoqiang Jiang, Nan Jing

|Dec 25, 2019
Naringenin Enhances the Antitumor Effect of Therapeutic Vaccines by Promoting Antigen Cross-Presentation.

Luoyang Wang, Wenfeng Zeng, Luyao Wang

Pageof 1

Frequent Collaborators

3 joint publications

Luoyang Wang

3 joint publications

Wei Liang

1 joint publications

Nan Jing

1 joint publications

Huiren Zhuang